Anti-obesity effects of Lactobacillus fermentum CQPC05 isolated from Sichuan pickle in high-fat diet-induced obese mice through PPAR-α signaling pathway

Microorganisms

Volumn 7, Issue 7, 2019, Pages

  Zhu, Kai ^a   Tan, Fang ^b   Mu, Jianfei ^a,c   Yi, Ruokun ^a   Zhou, Xianrong ^a,c   Zhao, Xin ^a  

^a CHONGQING UNIVERSITY OF EDUCATION   (China)

^b Our Lady of Fatima University   (Philippines)

^c SOUTHWEST UNIVERSITY   (China)

Author keywords

Anti obesity effect; Expression; Mice; PPAR signaling pathway; Sichuan pickle

Indexed keywords

EID: 85070857025     PISSN: None     EISSN: 20762607     Source Type: Journal    
DOI: 10.3390/microorganisms7070194     Document Type: Article

References (50)

1. Liu, B.H.; Yang, X.; Guo, L.J.; Zhang, J.; Zhou, X.R.; Yi, R.K.; Zhao, X. Inhibitory effect of Lactobacillus plantarum CQPC02 isolated from Chinese Sichuan pickles (Paocai) on constipation in mice. J. Food Qual. 2019, 2019, 9781914. [CrossRef]
2. Yang, J.X.; Zhang, L.L.; Jiang, H.Y.; He, Z.F. Isolation and identification of lactic bacteria in pickled vegetavles from Meishan city. Food Sci. 2015, 36, 158–163.
3. Liang, H.; Yin, L.; Zhang, Y.; Chang, C.; Zhang, W. Dynamics and diversity of a microbial community during the fermentation of industrialized Qingcai paocai, a traditional Chinese fermented vegetable food, as assessed by Illumina MiSeq sequencing, DGGE and qPCR assay. Ann. Microbiol. 2018, 68, 111–122. [CrossRef]
4. Chen, X.; Zhang, J.; Yi, R.; Mu, J.; Zhao, X.; Yang, Z. Hepatoprotective effects of Lactobacillus on carbon tetrachloride-induced acute liver injury in mice. Int. J. Mol. Sci. 2018, 19, 2212. [CrossRef] [PubMed]
5. Olivares, M.; Díaz-Ropero, M.A.; Gómez, N.; Lara-Villoslada, F.; Sierra, S.; Maldonado, J.A.; Martín, R.; López-Huertas, E.; Rodríguez, J.M.; Xaus, J. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int. J. Food Microbiol. 2006, 107, 104–111. [CrossRef]
6. Qian, Y.; Song, J.-L.; Yi, R.; Li, G.; Sun, P.; Zhao, X.; Huo, G. Preventive effects of Lactobacillus plantarum YS4 on constipation induced by activated carbon in mice. Appl. Sci. 2018, 8, 363. [CrossRef]
7. Chen, G.; Yu, W.H.; Zhang, Q.S.; Song, P.; Zhang, B.B.; Liu, Z.; You, J.G.; Li, H. Research of Sichuan Paocai and Lactic Acid Bacteria. Adv. J. Food Sci. Technol. 2014, 6, 1–5.
8. Huang, Y.; Luo, Y.B.; Zhai, Z.Y.; Zhang, H.X.; Yang, C.X.; Tian, H.T.; Li, Z.; Feng, J.N.; Liu, H.; Hao, Y.L. Characterization and application of an anti-Listeria bacteriocin produced by Pediococcus pentosaceus 05–10 isolated from Sichuan Pickle, a traditionally fermented vegetable product from China. Food Control. 2009, 20, 1030–1035. [CrossRef]
9. Chen, X.; Zhao, X.; Wang, H.; Yang, Z.; Li, J.; Suo, H. Prevent effects of Lactobacillus fermentum HY01 on dextran sulfate sodium-induced colitis in mice. Nutrients 2017, 9, 545. [CrossRef]
10. Chen, X.; Tan, F.; Yi, R.; Mu, J.; Zhao, X.; Yang, Z. Effects of Lactobacillus on mice with diabetes induced by high-fat diet with streptozotocin (STZ). Appl. Sci. 2018, 8, 1249. [CrossRef]
11. Ren, D.Y.; Li, C.; Qin, Y.Q.; Jin, N.Y. Development review on healthy function and potential mechanisms of lactic acid bacteria. Chin. J. Vet. Drug 2011, 45, 47–50.
12. Chen, D.W.; Yang, Z.Q.; Chen, X.; Huang, Y.J.; Yin, B.X.; Guo, F.X.; Zhao, H.Q.; Zhao, T.Y.; Qu, H.X.; Huang, J.D.; et al. The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. BMC Complement. Altern. Med. 2014, 14, 386. [CrossRef] [PubMed]
13. Luo, H.; Wang, X.Q.; Chen, C.C.; Wang, J.L.; Zou, X.; Li, C.W.; Xu, Z.C.; Yang, X.Y.; Shi, W.B.; Zeng, C.Y. Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats. J. Am. Heart Assoc. 2015, 4, e001559. [CrossRef] [PubMed]
14. Alisi, A.; Bedogni, G.; Baviera, G.; Giorgio, V.; Porro, E.; Paris, C.; Giammaria, P.; Reali, L.; Anania, F.; Nobili, V. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 2014, 39, 1276–1285. [PubMed]
15. Clément, K.; Ferré, P. Genetics and the pathophysiology of obesity. Pediatr. Res. 2003, 53, 721–725. [CrossRef] [PubMed]
16. Dayan, P.H.; Sforzo, G.; Boisseau, N.; Pereira-Lancha, L.O.; Lancha, A.H., Jr. A new clinical perspective: Treating obesity with nutritional coaching versus energy-restricted diets. Nutrition 2019, 60, 147–151. [CrossRef] [PubMed]
17. Finicelli, M.; Squillaro, T.; Di Cristo, F.; Di Salle, A.; Melone, M.A.B.; Galderisi, U.; Peluso, G. Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives. J. Cell Physiol. 2019, 234, 5807–5826. [CrossRef] [PubMed]
18. Asano, M.; Iwagaki, Y.; Sugawara, S.; Kushida, M.; Okouchi, R.; Yamamoto, K.; Tsuduki, T. Effects of Japanese diet in combination with exercise on visceral fat accumulation. Nutrition 2019, 57, 173–182. [CrossRef]
19. Appiakannan, H.S.; Kestyus, D.R.; Weber, E.T. Effects of high fat diet and chronic circadian challenge on glucocorticoid regulation in C57BL/6J mice. Physiol. Behav. 2019, 204, 100–105. [CrossRef]
20. Corrêa, T.A.; Rogero, M.M. Polyphenols regulating microRNAs and inflammation biomarkers in obesity. Nutrition 2019, 59, 150–157. [CrossRef]
21. Kim, D.H.; Jeong, D.; Kang, I.B.; Kim, H.; Song, K.Y.; Seo, K.H. Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: Direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue. Mol. Nutr. Food Res. 2017, 61, 1700252. [CrossRef] [PubMed]
22. Maleki Kakelar, H.; Barzegari, A.; Hanifian, S.; Barar, J.; Omidi, Y. Isolation and molecular identification of Lactobacillus with probiotic potential from abomasums driven rennet. Food Chem. 2019, 272, 709–714. [CrossRef]
23. Zhang, J.; Zhou, X.; Chen, B.; Long, X.; Mu, J.; Pan, Y.; Song, J.L.; Zhao, X.; Yang, Z. Preventive effect of Lactobacillus plantarum CQPC10 on activated carbon induced constipation in Institute of Cancer Research (ICR) Mice. Appl. Sci. 2018, 8, 1498. [CrossRef]
24. Tanida, M.; Shen, J.; Maeda, K.; Horii, Y.; Yamano, T.; Fukushima, Y.; Nagai, K. High-fat diet-induced obesity is attenuated by probiotic strain Lactobacillus paracasei ST11 (NCC2461) in rats. Obes Res. Clin. Pract. 2008, 2, 159–169. [CrossRef]
25. Rather, S.A.; Pothuraju, R.; Sharma, R.K.; De, S.; Mir, N.A.; Jangra, S. Anti-obesity effect of feeding probiotic dahi containing Lactobacillus casei NCDC 19 in high fat diet-induced obese mice. Int. J. Dairy Technol. 2014, 67, 504–509. [CrossRef]
26. Toral, M.; Gómez-Guzmán, M.; Jiménez, R.; Romero, M.; Sánchez, M.; Utrilla, M.P.; Garrido-Mesa, N.; Rodríguez-Cabezas, M.E.; Olivares, M.; Gálvez, J.; et al. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin. Sci. 2014, 127, 33–45. [CrossRef]
27. Thornton, B.; Basu, C. Real-time PCR (qPCR) primer design using free online software. Biochem. Mol. Biol. Educ. 2011, 39, 145–154. [CrossRef]
28. Bustina, S.; Huggett, J. qPCR primer design revisited. Biomol. Detect. Quantif. 2017, 14, 19–28. [CrossRef]
29. Qian, Y.; Zhang, J.; Zhou, X.; Yi, R.; Mu, J.; Long, X.; Pan, Y.; Zhao, X.; Liu, W. Lactobacillus plantarum CQPC11 isolated from sichuan pickled cabbages antagonizes d-galactose-induced oxidation and aging in mice. Molecules 2018, 23, 3026. [CrossRef]
30. 4-induced hepatic damage in mice through its antioxidant capacities. Nutrients 2018, 10, 1280. [CrossRef]
31. Al Zarzour, R.H.; Ahmad, M.; Asmawi, M.Z.; Kaur, G.; Saeed, M.A.A.; Al-Mansoub, M.A.; Saghir, S.A.M.; Usman, N.S.; Al-Dulaimi, D.W.; Yam, M.F. Phyllanthus Niruri standardized extract alleviates the progression of non-alcoholic fatty liver disease and decreases atherosclerotic risk in Sprague-Dawley Rats. Nutrients 2017, 9, 766. [CrossRef] [PubMed]
32. Panelli, M.F.; Pierine, D.T.; De Souza, S.L.B.; Ferron, A.J.T.; Garcia, J.L.; Santos, K.C.; Belin, M.A.F.; Lima, G.P.P.; Borguini, M.G.; Minatel, I.O.; et al. Bark of Passiflora edulis treatment stimulates antioxidant capacity, and reduces dyslipidemia and body fat in db/db mice. Antioxidants 2018, 7, 120. [CrossRef] [PubMed]
33. Zhang, Y.; Yang, J.; Ye, J.; Guo, Q.; Wang, W.; Sun, Y.; Zeng, Q. Separate and combined associations of physical activity and obesity with lipid-related indices in non-diabetic and diabetic patients. Lipids Health Dis. 2019, 18, 49. [CrossRef] [PubMed]
34. Xu, M.X.; Sun, Y.; Dai, X.L.; Zhan, J.X.; Long, T.T.; Xiong, M.X.; Li, H.H.; Kuang, Q.; Tang, T.T.; Qin, Y.T.; et al. Fisetin attenuates high fat diet-triggered hepatic lipid accumulation: A mechanism involving liver inflammation overload associated TACE/TNF-α pathway. J. Funct. Foods 2019, 53, 7–21.
35. Lee, S.; Han, D.; Kang, H.; Jeong, S.J.; Jo, J.E.; Shin, J.; Kim, D.K.; Park, H.W. Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance. Biomaterials 2019, 197, 1–11. [CrossRef] [PubMed]
36. Khajebishak, Y.; Payahoo, L.; Alivand, M.; Alipour, B. Punicic acid: A potential compound of pomegranate seed oil in Type 2 diabetes mellitus management. J. Cell. Physiol. 2019, 234, 2112–2120. [CrossRef] [PubMed]
37. Kang, M.J.; Kim, K.K.; Son, B.Y.; Nam, S.W.; Shin, P.G.; Kim, G.D. The anti-adipogenic activity of a new cultivar, Pleurotus eryngii var. ferulae ’Beesan No. 2’, through down-regulation of PPAR γ and C/EBP α in 3T3-L1 cells. J. Microbiol. Biotechnol. 2016, 26, 1836–1844. [CrossRef]
38. Kim, H.J.; You, M.K.; Lee, Y.H.; Kim, H.J.; Adhikari, D.; Kim, H.A. Red pepper seed water extract inhibits preadipocyte differentiation and induces mature adipocyte apoptosis in 3T3-L1 cells. Nutr. Res. Pract. 2018, 12, 494–502. [CrossRef]
39. Lundsgaard, A.M.; Fritzen, A.M.; Kiens, B. Molecular regulation of fatty acid oxidation in skeletal muscle during aerobic exercise. Trends Endocrinol. Metab. 2018, 29, 18–30. [CrossRef]
40. Colom, C.; Viladés, D.; Pérez-Cuellar, M.; Leta, R.; Rivas-Urbina, A.; Carreras, G.; Ordóñez-Llanos, J.; Pérez, A.; Sánchez-Quesada, J.L. Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes. Cardiovasc. Diabetol. 2018, 17, 156. [CrossRef]
41. Su, X.; Kong, Y.; Peng, D. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients. Lipids Health Dis. 2018, 17, 174. [CrossRef] [PubMed]
42. Cruciani-Guglielmacci, C.; Magnan, C. Brain lipoprotein lipase as a regulator of energy balance. Biochimie 2017, 143, 51–55. [CrossRef] [PubMed]
43. Yang, D.; Hu, C.; Deng, X.; Bai, Y.; Cao, H.; Guo, J.; Su, Z. Therapeutic effect of chitooligosaccharide tablets on lipids in high-fat diets induced hyperlipidemic rats. Molecules 2019, 24, 514. [CrossRef] [PubMed]
44. Tanaka, Y.; Ikeda, T.; Yamamoto, K.; Masuda, S.; Ogawa, H.; Kamisako, T. Gender-divergent expression of lipid and bile acid metabolism-related genes in adult mice offspring of dams fed a high-fat diet. J. Biosci. 2018, 43, 329–337. [CrossRef] [PubMed]
45. Stephens, R.W.; Arhire, L.; Covasa, M. Gut microbiota: From microorganisms to metabolic organ influencing obesity. Obesity 2018, 26, 801–809. [CrossRef] [PubMed]
46. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022–1023. [CrossRef] [PubMed]
47. Hegde, V.; Dhurandhar, N.V. Microbes and obesity–interrelationship between infection, adipose tissue and the immune system. Clin. Microbiol. Infect. 2013, 19, 314–320. [CrossRef] [PubMed]
48. Roselli, M.; Devirgiliis, C.; Zinno, P.; Guantario, B.; Finamore, A.; Rami, R.; Perozzi, G. Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition. Genes Nutr. 2017, 12, 25. [CrossRef]
49. Le Barz, M.; Anhê, F.F.; Varin, T.V.; Desjardins, V.; Levy, E.; Roy, D.; Urdaci, M.C.; Marette, A. Probiotics as complementary treatment for metabolic disorders. Diabetes Metab. J. 2015, 39, 291–303. [CrossRef]
50. Anhê, F.F.; Nachbar, R.T.; Varin, T.V.; Trottier, J.; Dudonné, S.; Le Barz, M.; Feutry, P.; Pilon, G.; Barbier, O.; Desjardins, Y.; et al. Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice. Gut 2019, 68, 453–464. [CrossRef]